RxDoctor Payments Data

Hope Ferguson, MD

Family Medicine · Mc Cook, NENPI 1487147633

Payments from drug & device makers

$854in general payments, 2019–2025

Across 54 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$146
  • Pfizer$104
  • Electromed, Inc.$100
  • Astellas Pharma US Inc$55
  • Boehringer Ingelheim$46
  • Lilly USA, LLC$40
  • plus $363 from 15 others

What the payments were for

  • Food & beverage$80494%
  • Other$516%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$854 in reported general payments places this provider in the 55th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$151,465
Medicare patients
350
Services billed
5,234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban107$57,290
XareltoRivaroxaban66$47,256
OzempicSemaglutide48$44,676
JardianceEmpagliflozin34$20,687
MounjaroTirzepatide20$20,428
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$19,639
FarxigaDapagliflozin Propanediol33$17,464
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$16,397
JanuviaSitagliptin Phosphate30$15,585
MyrbetriqMirabegron32$13,366
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$10,792
Soliqua 100-33Insulin Glargine/Lixisenatide11$9,899
DuleraMometasone/Formoterol12$4,315
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$3,378
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,978

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$104$57,290107 claims
Johnson & JohnsonXarelto$39$47,25666 claims
Novo NordiskOzempic$146$44,67648 claims
AstraZenecaFarxiga, Breztri Aerosphere$15$33,86159 claims
Boehringer IngelheimJardiance$46$20,68734 claims
Lilly USA, LLCMounjaro$40$20,42820 claims
MerckJanuvia, Dulera$20$19,90042 claims
Astellas Pharma US IncMyrbetriq$55$13,36632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Mc Cook

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →